MoneyWorks4Me

The revenue for the March 2024 quarter is pegged at Rs. 9648.00 millions, about 23.50% up against Rs. 7812.00 millions recorded during the year-ago period.A good growth in profit of 37.39% reported to Rs. 3491.00  millions over Rs. 2541.00 millions of corresponding previous quarter.Operating profit surged to 4886.00 millions from the corresponding previous quarter of 3452.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 9648.00 7812.00 23.50 35689.00 23510.00 51.80 35689.00 23510.00 51.80
Other Income 359.00 175.00 105.14 1047.00 855.00 22.46 1047.00 855.00 22.46
PBIDT 4886.00 3452.00 41.54 17417.00 9302.00 87.24 17417.00 9302.00 87.24
Interest 45.00 12.00 275.00 145.00 86.00 68.60 145.00 86.00 68.60
PBDT 4841.00 3440.00 40.73 17272.00 9216.00 87.41 17272.00 9216.00 87.41
Depreciation 516.00 376.00 37.23 1719.00 1509.00 13.92 1719.00 1509.00 13.92
PBT 4325.00 3064.00 41.16 15553.00 7707.00 101.80 15553.00 7707.00 101.80
TAX 834.00 523.00 59.46 2487.00 1336.00 86.15 2487.00 1336.00 86.15
Deferred Tax -2.00 24.00 -108.33 -361.00 5.00 -7320.00 -361.00 5.00 -7320.00
PAT 3491.00 2541.00 37.39 13066.00 6371.00 105.09 13066.00 6371.00 105.09
Equity 358.00 365.00 -1.92 358.00 365.00 -1.92 358.00 365.00 -1.92
PBIDTM(%) 50.64 44.19 14.61 48.80 39.57 23.34 48.80 39.57 23.34
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..